According to Amylyx Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -NZ$0.26 B. In 2023 the company made an earning of NZ$62.71 M an increase over its 2022 earnings that were of -NZ$0.33 B.The earnings displayed on this page is the company's Pretax Income.